What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Schizophrenia
- Gene
His primary areas of study are Internal medicine, Endocrinology, Schizophrenia, Psychiatry and Clozapine.
His Internal medicine research is multidisciplinary, relying on both Anesthesia, Pharmacogenetics, Pharmacology and Depression.
His Endocrinology research focuses on Serotonin and how it connects with Platelet.
His Schizophrenia study combines topics from a wide range of disciplines, such as Psychosis, Neuroscience, Clinical psychology and Verbal fluency test.
Many of his research projects under Psychiatry are closely connected to Suicide prevention with Suicide prevention, tying the diverse disciplines of science together.
His research in Clozapine intersects with topics in Extrapyramidal symptoms, Antipsychotic, Atypical antipsychotic, Mechanism of action and Haloperidol.
His most cited work include:
- Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine (3267 citations)
- Practice guideline for the treatment of patients with schizophrenia (1253 citations)
- Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression (1234 citations)
What are the main themes of his work throughout his whole career to date?
Herbert Y. Meltzer spends much of his time researching Internal medicine, Endocrinology, Schizophrenia, Psychiatry and Pharmacology.
His Endocrinology research incorporates elements of Receptor and Serotonergic.
Herbert Y. Meltzer frequently studies issues relating to Psychosis and Schizophrenia.
His work on Psychopathology, Cognition and Schizophrenia as part of general Psychiatry study is frequently linked to Suicide prevention, therefore connecting diverse disciplines of science.
His Pharmacology study combines topics in areas such as Haloperidol, Antagonist, Dopamine receptor D2, 5-HT receptor and Phencyclidine.
As a part of the same scientific study, Herbert Y. Meltzer usually deals with the Clozapine, concentrating on Atypical antipsychotic and frequently concerns with Melperone.
He most often published in these fields:
- Internal medicine (48.88%)
- Endocrinology (39.89%)
- Schizophrenia (28.35%)
What were the highlights of his more recent work (between 2009-2021)?
- Schizophrenia (28.35%)
- Internal medicine (48.88%)
- Antipsychotic (14.72%)
In recent papers he was focusing on the following fields of study:
Schizophrenia, Internal medicine, Antipsychotic, Pharmacology and Clozapine are his primary areas of study.
His Schizophrenia research is included under the broader classification of Psychiatry.
His Psychiatry research includes elements of Clinical trial and Clinical psychology.
His Internal medicine research incorporates themes from Endocrinology, Olanzapine, Oncology and Single-nucleotide polymorphism.
The concepts of his Pharmacology study are interwoven with issues in Phencyclidine, Agonist, Partial agonist and Dopamine receptor D2, Dopamine.
Clozapine is frequently linked to Atypical antipsychotic in his study.
Between 2009 and 2021, his most popular works were:
- Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: The MIND randomized, placebo-controlled trial (318 citations)
- Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology (301 citations)
- The role of serotonin receptors in the action of atypical antipsychotic drugs. (251 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Schizophrenia
The scientist’s investigation covers issues in Pharmacology, Atypical antipsychotic, Schizophrenia, Internal medicine and Antipsychotic.
His studies in Pharmacology integrate themes in fields like Agonist, Inverse agonist, Lurasidone, Pimavanserin and Phencyclidine.
His Atypical antipsychotic study incorporates themes from Haloperidol, Clozapine, Amisulpride and Dopamine receptor D2.
His Schizophrenia study is concerned with the field of Psychiatry as a whole.
His work deals with themes such as Tolerability and Clinical trial, which intersect with Psychiatry.
Herbert Y. Meltzer has researched Internal medicine in several fields, including Schizoaffective disorder, Endocrinology and Olanzapine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
